BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/27/2024 1:28:19 PM | Browse: 469 | Download: 1214
Publication Name World Journal of Hepatology
Manuscript ID 90541
Country Germany
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Infectious Diseases
Manuscript Type Retrospective Study
Article Title Retrospective study of the incidence, risk factors, treatment outcomes of bacterial infections at uncommon sites in cirrhotic patients
Manuscript Source Unsolicited Manuscript
All Author List Sophie Schneitler, Christina Schneider, Markus Casper, Frank Lammert, Marcin Krawczyk, Sören L Becker and Matthias Christian Reichert
ORCID
Author(s) ORCID Number
Sophie Schneitler http://orcid.org/0000-0002-5766-9894
Christina Schneider http://orcid.org/0009-0000-7518-077X
Markus Casper http://orcid.org/0000-0002-1146-288X
Frank Lammert http://orcid.org/0000-0003-4450-7201
Marcin Krawczyk http://orcid.org/0000-0002-0113-0777
Sören L Becker http://orcid.org/0000-0003-3634-8802
Matthias Christian Reichert http://orcid.org/0000-0002-8192-0575
Funding Agency and Grant Number
Corresponding Author Sophie Schneitler, MD, Consultant Physician-Scientist, Institute of Medical Microbiology and Hygiene, Saarland University, Kirrberger Straße 100, Homburg 66421, Germany. sophie.schneitler@uks.eu
Key Words Bacterial infection; Empirical antibiotic therapy; End-stage liver disease; Escherichia coli; Multi-resistant pathogens
Core Tip Bacterial infections (BI) affect the natural course of liver cirrhosis and can trigger decompensation or death. The most frequent BI in cirrhosis (urinary tract infections, pneumonia or spontaneous-bacterial peritonitis were retrospectively compared to infections at other body sites, which are thought to be less frequently affected (so-called “atypical BI”). When comparing typical/atypical BI, no differences in age, sex, or etiology of cirrhosis were found. Notably, for atypical BI, the stage of cirrhosis was less advanced, as expressed by laboratory parameters and clinical scores (e.g. Model of End Stage Liver Disease - and Child-Pugh-Score).
Publish Date 2024-03-27 13:28
Citation Schneitler S, Schneider C, Casper M, Lammert F, Krawczyk M, Becker SL, Reichert MC. Retrospective study of the incidence, risk factors, treatment outcomes of bacterial infections at uncommon sites in cirrhotic patients. World J Hepatol 2024; 16 (3): 418-427
URL https://www.wjgnet.com/1948-5182/full/v16/i3/418.htm
DOI https://dx.doi.org/10.4254/wjh.v16.i3.418
Full Article (PDF) WJH-16-418-with-cover.pdf